Quality of life (QL) in a randomised controlled trial of dose intensified chemotherapy with or without rHuG-CSF (lenograstim) in small cell lung cancer (SCLC)
Keyword(s):
2020 ◽
Vol 21
(4)
◽
pp. 581-592
◽
2016 ◽
Vol 387
(10027)
◽
pp. 1540-1550
◽
2006 ◽
Vol 7
(9)
◽
pp. 719-727
◽